Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

TET2 and LILRB1 mutations are frequent in Epstein-Barr virus-positive diffuse large B-cell lymphoma especially in elderly patients.

Cancer - 15 May 2023

Cho Junhun, Kim Eojin, Yoon Sang Eun, Kim Seok Jin, Kim Won Seog

Abstract excerpt

BACKGROUND: Diffuse large B-cell lymphoma (DLBCL) harboring Epstein-Barr virus (EBV) primarily occurs in patients who have underlying immunodeficiency or in elderly patients but is also reported in young, immunocompetent patients. The authors investigated the pathologic differences in EBV-positive DLBCL in these three groups of patients. METHODS: In total, 57 patients with EBV-positive DLBCL were included in the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antigens, CD
Share to B7-H1 Antigen
Share to Dioxygenases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA-Binding Proteins

Share to Epstein-Barr Virus Infections

Share to Epstein-Barr Virus Nuclear Antigens

Share to Herpesvirus 4, Human

Share to Lymphoma, Large B-Cell, Diffuse

Source

Identifiers

PMID: 36812290
DOI: 10.1002/cncr.34698

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

TET2 and LILRB1 mutations are frequent in Epstein-Barr virus-positive diffuse large B-cell lymphoma especially in elderly patients.PMID 36812290Read ↗

TET2 and LILRB3 mutations are frequent in EBV-positive diffuse large B-cell lymphoma especially in elderly patientsSemantic proximity Read ↗

Oncogenic Mutations and Tumor Microenvironment Alterations of Older Patients With Diffuse Large B-Cell Lymphoma.Semantic proximity Read ↗

A microRNA signature profile in EBV+ diffuse large B-cell lymphoma of the elderlySemantic proximity Read ↗

Comprehensive Genomic Profiling of EBV-Positive Diffuse Large B-cell Lymphoma and the Expression and Clinicopathological Correlations of Some Related GenesSemantic proximity Read ↗

Somatic mutations in KMT2D and TET2 associated with worse prognosis in Epstein-Barr virus-associated T or natural killer-cell lymphoproliferative disordersSemantic proximity Read ↗

B2M mutation paves the way for immune tolerance in pathogenesis of Epstein-Barr virus positive diffuse large B-cell lymphomasSemantic proximity Read ↗

Clinicopathological Findings of Systemic Epstein-Barr-Positive CD8-positive T-lymphoproliferative Diseases in Younger and Older Patients Semantic proximity Read ↗

Prevalence of targetable oncogenic mutations and genomic alterations in Epstein-Barr virus-associated diffuse large B-cell lymphoma of the elderly.Semantic proximity Read ↗

Epstein–Barr Virus and the Pathogenesis of Diffuse Large B-Cell LymphomaSemantic proximity Read ↗

EBV+ nodal T/NK-cell lymphoma associated with clonal hematopoiesis and structural variations of the viral genome.Semantic proximity Read ↗

Born with Two Faces: Sequential development of Diffuse Large B-cell Lymphoma and Angioimmunoblastic T-cell Lymphoma with EBV positive and TET2 mutationSemantic proximity Read ↗

Clinical efficacy and molecular biomarkers in a phase II study of tucidinostat plus R-CHOP in elderly patients with newly diagnosed diffuse large B-cell lymphoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.